- Release Date: 10/07/14 11:47
- Summary: Neuren receives ethics approval to start Concussion trial
- Price Sensitive: Yes
- Download Document 103.23KB
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren receives ethics approval to start Concussion trial
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.29%
!
$17.47

Ann: Neuren receives ethics approval to start Concussion trial
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.47 |
Change
-0.410(2.29%) |
Mkt cap ! $2.219B |
Open | High | Low | Value | Volume |
$17.93 | $18.06 | $17.46 | $10.18M | 572.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 799 | $17.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.47 | 132 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11 | 17.480 |
5 | 154 | 17.470 |
16 | 1551 | 17.460 |
5 | 755 | 17.450 |
4 | 917 | 17.440 |
Price($) | Vol. | No. |
---|---|---|
17.490 | 463 | 7 |
17.500 | 1141 | 20 |
17.510 | 1245 | 15 |
17.520 | 771 | 8 |
17.530 | 940 | 6 |
Last trade - 14.30pm 13/08/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |